Activists in the state of Michigan have filed a ballot measure that will legalize the possession, cultivation and sharing of psychedelic substances as well as establish a system for the spiritual and therapeutic use of psychedelics, if approved. The Students for Sensible Drug Policy, a youth-led organization, and the Michigan Chapter of Decriminalize Nature worked together on this effort. The state’s ballot initiative would legalize various entheogenic substances, including DMT, peyote, mescaline, ibogaine, psilocin and psilocybin, for individuals aged 18 and above.
During a recent interview, codirector of Decriminalize Nature Michigan Myc Williams stated that the two groups were excited to have filed the initiative and looked forward to receiving approval from the State Board of Canvassers. The measure would permit the therapeutic, guidance, supervision, counseling, spiritual, harm reduction and related supportive services with or without remuneration.
It would also authorize entities designated by a psychiatric hospital or a medical hospital that have a “certificate of need” from the Department of Health and Human Services in the state to grow and sell psychedelic substances to individuals who have a written recommendation from their physicians. In addition to legalizing psychedelics, the initiative also proposes that some drug statutes be amended in order to decrease criminal penalties for the possession of any other controlled substances categorized under Schedule I or II of Michigan law. The measure would also protect individuals from being prosecuted for “unusable, residual or minuscule” amounts of drugs found on paraphernalia and remove testing equipment that determines the purity and potency of drugs.
Executive director of the Students for Sensible Drug Policy Jason Ortiz stated in an interview that the group was proud to have advocated for a policy that would decrease the criminalization of individuals who use drugs.
The activists plan to refile their initiative soon, as the deadline to submit explanatory material and/or proposed summary language to the Board of State Canvassers is February 8. This isn’t the first time activists in the state of Michigan advanced psychedelic reform measures. Late last year, the city council of Ann Arbor made the enforcement of laws that prohibit psychedelics such as DMT, ayahuasca and psilocybin among its lowest priorities. In November, voters in Detroit also approved a ballot measure to decriminalize psychedelic substances. Earlier in September, the city council of Grand Rapids also approved a measure that supported the decriminalization of a range of psychedelics.
In the same month, two state senators also introduced a measure to legalize the possession, growing and delivery of fungi- and plant-derived psychedelics, including mescaline and psilocybin.
This wave of psychedelic policy reform is likely to have a beneficial effect upon the valuations of sector companies such as Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF), especially when they come up with breakthrough remedies that treat conditions that have been hard to treat using existing medicines.
NOTE TO INVESTORS: The latest news and updates relating to Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) are available in the company’s newsroom at https://ibn.fm/MYCOF
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)
For more information please visit https://www.psychedelicnewswire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.
